Site Map    |    Contact    |    

Share  | 

About Protalix

 

We are a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on our proprietary ProCellEx®protein expression system.More

Patients

 

Protalix is developing therapies that may potentially address Gaucher disease, Fabry disease and autoimmune disease (including rheumatoid arthritis). For more information on Protalix’s phase III study in Fabry disease , please click here or please email us
More

Learn More Learn More Learn More Learn More Learn More Learn More